SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for SOBR Safe, Inc. (SOBR) (CIK 0001425627) (SOBR) — Sep 25, 2014

SOBR Safe, Inc. (SOBR) (CIK 0001425627)
Date: Sept. 25, 2014 · CIK: 0001425627 · Accession: 0000000000-14-048182

Regulatory Compliance Financial Reporting Internal Controls

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
September 25, 2014
Author
/s/ Lyn Shenk
Form
UPLOAD
Company
SOBR Safe, Inc. (SOBR) (CIK 0001425627)

Letter

September 25, 2014 Via E -mail Charles Bennington President Transbiotec, Inc. 400 N. Tustin Ave, Suite 225 Santa Ana, CA 92705

RE: Transbiotec, Inc. Item 4.01 Form 8 -K Filed April 15 , 201 4 File No. 000 -53316

Dear Mr. Bennington :

We issued comments to you on the above captioned filing on June 27, 2014 . As of the date of this letter, these comments remain outstanding and unresolved. We expect you to provide a complete, substantive response to these comments by October 6, 2014 .

If you do not respond , we will, consistent with our obligations under the federal securities laws, decide how we will seek to resolve material outstanding comments and complete our review of this matter . Among other things, we may decide to release publicly, through the agency’s EDGAR system, all correspondence, including this letter, relating to the review of this matter , consistent with the staff’s decision to release publicly comment letters and response letters relating to matters it has reviewed. You can find more information about the staff’s decision to release filing correspondence at http://www.sec.gov/divisions/corpfin/cfannouncements/edgarcorrespondence.htm , http://www.sec.gov/news/press/2004 -89.htm and http://www.sec.gov /news/press/2005 -72.htm .

Please contact Patrick Kuhn at (202) 551-3308 with any questions. You may also contact me at (202) 551-3380.

Sincerely,
/s/ Lyn Shenk

Show Raw Text
September  25, 2014

Via E -mail
Charles Bennington
President
Transbiotec, Inc.
400 N. Tustin Ave, Suite 225
Santa Ana, CA 92705

 RE:  Transbiotec, Inc.
   Item 4.01 Form 8 -K
   Filed April 15 , 201 4
   File No. 000 -53316

Dear Mr. Bennington :

 We issued comments to you on the above captioned filing on June 27, 2014 .  As of the
date of this letter, these comments remain outstanding and unresolved.  We expect you to
provide a complete, substantive response to these comments by  October  6, 2014 .

 If you do not respond , we will, consistent with our obligations under the federal securities
laws, decide how we will seek to resolve material outstanding comments and complete our
review of this matter .  Among other things, we may decide to release publicly, through the
agency’s EDGAR system, all correspondence, including this letter, relating to the review of this
matter , consistent with the staff’s decision to release publicly comment  letters and response
letters relating to matters  it has reviewed.  You can find more information about the staff’s
decision to release filing correspondence at
http://www.sec.gov/divisions/corpfin/cfannouncements/edgarcorrespondence.htm ,
http://www.sec.gov/news/press/2004 -89.htm  and http://www.sec.gov /news/press/2005 -72.htm .

Please contact Patrick Kuhn  at (202) 551-3308 with any questions.  You may also contact
me at (202) 551-3380.

 Sincerely,

        /s/ Lyn Shenk

 Lyn Shenk
 Branch Chief